13878 Federal Register / Vol. 78, No. 41 / Friday, March 1, 2013 / Notices 

FEDERAL RESERVE SYSTEM 

Formations of, Acquisitions by, and 

Mergers of Bank Holding Companies 

The companies listed in this notice 

have applied to the Board for approval, 

pursuant to the Bank Holding Company 

Act of 1956 (12 U.S.C. 1841 et seq.) 

(BHC Act), Regulation Y (12 CFR part 

225), and all other applicable statutes 

and regulations to become a bank 

holding company and/or to acquire the 

assets or the ownership of, control of, or 

the power to vote shares of a bank or 

bank holding company and all of the 

banks and nonbanking companies 

owned by the bank holding company, 

including the companies listed below. 

The applications listed below, as well 

as other related filings required by the 

Board, are available for immediate 

inspection at the Federal Reserve Bank 

indicated. The applications will also be 

available for inspection at the offices of 

the Board of Governors. Interested 

persons may express their views in 

writing on the standards enumerated in 

the BHC Act (12 U.S.C. 1842(c)). If the 

proposal also involves the acquisition of 

a nonbanking company, the review also 

includes whether the acquisition of the 

nonbanking company complies with the 

standards in section 4 of the BHC Act 

(12 U.S.C. 1843). Unless otherwise 

noted, nonbanking activities will be 

conducted throughout the United States. 

Unless otherwise noted, comments 

regarding each of these applications 

must be received at the Reserve Bank 

indicated or the offices of the Board of 

Governors not later than March 28, 

2013. 

A. Federal Reserve Bank of Kansas 

City (Dennis Denney, Assistant Vice 

President) 1 Memorial Drive, Kansas 

City, Missouri 64198–0001: 

1. Eagle Bancshares, Inc., Eagle, 

Nebraska; to become a bank holding 

company by acquiring 100 percent of 

the voting shares of Eagle State Bank, 

Eagle, Nebraska. 

Board of Governors of the Federal Reserve 

System, February 25, 2013. 

Margaret McCloskey Shanks, 

Deputy Secretary of the Board. 

[FR Doc. 2013–04765 Filed 2–28–13; 8:45 am] 

BILLING CODE 6210–01–P 

FEDERAL RESERVE SYSTEM 

Formations of, Acquisitions by, and 

Mergers of Bank Holding Companies 

The companies listed in this notice 

have applied to the Board for approval, 

pursuant to the Bank Holding Company 

Act of 1956 (12 U.S.C. 1841 et seq.) 

(BHC Act), Regulation Y (12 CFR part 

225), and all other applicable statutes 

and regulations to become a bank 

holding company and/or to acquire the 

assets or the ownership of, control of, or 

the power to vote shares of a bank or 

bank holding company and all of the 

banks and nonbanking companies 

owned by the bank holding company, 

including the companies listed below. 

The applications listed below, as well 

as other related filings required by the 

Board, are available for immediate 

inspection at the Federal Reserve Bank 

indicated. The applications will also be 

available for inspection at the offices of 

the Board of Governors. Interested 

persons may express their views in 

writing on the standards enumerated in 

the BHC Act (12 U.S.C. 1842(c)). If the 

proposal also involves the acquisition of 

a nonbanking company, the review also 

includes whether the acquisition of the 

nonbanking company complies with the 

standards in section 4 of the BHC Act 

(12 U.S.C. 1843). Unless otherwise 

noted, nonbanking activities will be 

conducted throughout the United States. 

Unless otherwise noted, comments 

regarding each of these applications 

must be received at the Reserve Bank 

indicated or the offices of the Board of 

Governors not later than March 25, 

2013. 

A. Federal Reserve Bank of Kansas 

City (Dennis Denney, Assistant Vice 

President) 1 Memorial Drive, Kansas 

City, Missouri 64198–0001: 

1. BancFirst Corporation, Oklahoma 

City, Oklahoma; to acquire control of 

Spirit Bankcorp, Inc., Bristow, 

Oklahoma, and thereby indirectly 

acquire voting shares of SpiritBank, 

Tulsa, Oklahoma. 

Board of Governors of the Federal Reserve 

System, February 25, 2013. 

Margaret McCloskey Shanks, 

Deputy Secretary of the Board. 

[FR Doc. 2013–04766 Filed 2–28–13; 8:45 am] 

BILLING CODE 6210–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifiers CMS–588 and CMS– 

10169] 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, HHS. 

In compliance with the requirement 

of section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995, the 

Centers for Medicare & Medicaid 

Services (CMS) is publishing the 

following summary of proposed 

collections for public comment. 

Interested persons are invited to send 

comments regarding this burden 

estimate or any other aspect of this 

collection of information, including any 

of the following subjects: (1) The 

necessity and utility of the proposed 

information collection for the proper 

performance of the agency’s functions; 

(2) the accuracy of the estimated 

burden; (3) ways to enhance the quality, 

utility, and clarity of the information to 

be collected; and (4) the use of 

automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

1. Type of Information Collection 

Request: Revision of a currently 

approved collection. Title of 

Information Collection: Electronic 

Funds Transfers Authorization 

Agreement Use: The primary function of 

the Electronic Funds Transfer 

Authorization Agreement (CMS 588) is 

to gather information from a provider/ 

supplier to establish an electronic 

payment process. 

The legal authority to collect this 

information is found in Section 1815(a) 

of the Social Security Act. This section 

provides authority for the Secretary of 

Health and Human Services to pay 

providers/suppliers of Medicare 

services. Under 31 U.S.C. 3332(f)(1), all 

federal payments, including Medicare 

payments to providers and suppliers, 

shall be made by electronic funds 

transfer. 31 U.S.C. 7701 (c) requires that 

any person or entity doing business 

with the federal government must 

provide their Tax Identification Number 

(TIN). 

The goal of this submission is to 

renew the data collection. Only two 

minor revisions for systems 

requirements will be made at this time, 

specifically adding a street address line 

for the location of the financial 

institution and adding an additional 

National Provider Identification (NPI) 

number collection field for those 

providers/suppliers who have more 

than one NPI. Form Number: CMS–588 

(OCN: 0938–0626). Frequency: 

Occasionally. Affected Public: Private 

Sector (business or other for-profits) and 

Not-for-profit institutions. Number of 

Respondents: 94,000. Total Annual 

Responses: 94,000. Total Annual Hours: 

23,500. (For policy questions regarding 

this collection contact Kim McPhillips 

at 410–786–5374. For all other issues 

call 410–786–1326.) 

mstockstill on DSK4VPTVN1PROD with NOTICES

Federal Register / Vol. 78, No. 41 / Friday, March 1, 2013 / Notices 13879 

2. Type of Information Collection 

Request: Revision of a currently 

approved collection. Title of 

Information Collection: Medicare 

Durable Medical Equipment, 

Prosthetics, Orthotics and Supplies 

(DMEPOS) Competitive Bidding 

Program. Use: Since 1989, Medicare has 

been paying for durable medical 

equipment (DME) and supplies (other 

than customized items) using fee 

schedule amounts that are calculated for 

each item or category of DME identified 

by a Healthcare Common Procedure 

Coding System code. Payments are 

based on the average supplier charges 

on Medicare claims from 1986 and 1987 

and are updated annually on a factor 

legislated by Congress. For many years, 

the Government Accountability Office 

and the Office of Inspector General of 

the U.S. Department of Health and 

Human Services have reported that 

these fees are often highly inflated and 

that Medicare has paid higher than 

market rates for several different types 

of DME. Due to reports of Medicare 

overpayment of DME and supplies, 

Congress required that CMS conduct a 

competitive bidding demonstration 

project for these items. Accordingly, 

CMS implemented a demonstration 

project for this program from 1999–2002 

which produced significant savings for 

beneficiaries and taxpayers without 

hindering access to DMEPOS and 

related services. Shortly after a 

successful demonstration of the 

competitive bidding program, Congress 

passed the Medicare Prescription Drug, 

Improvement and Modernization Act of 

2003 and mandated a phased-in 

approach to implement this program 

over the course of several years 

beginning in 2007 in 10 metropolitan 

statistical areas (MSAs). The statute 

specifically required the Secretary to 

establish and implement programs 

under which competitive bidding areas 

are established throughout the United 

States for contract award purposes for 

the furnishing of certain competitively 

priced items and services for which 

payment is made under Medicare Part 

B. This program is commonly known as 

the ‘‘Medicare DMEPOS Competitive 

Bidding Program.’’ 

CMS conducted its first round of 

bidding for the Medicare DMEPOS 

Competitive Bidding Program in 2007 

with the help of its contractor, the 

Competitive Bidding Implementation 

Contractor. CMS published a Request 

for Bids instructions and accompanying 

forms for suppliers to submit their bids 

to participate in the program. During 

this first round of bidding, DMEPOS 

suppliers from across the U.S. submitted 

bids identifying the MSA(s) to service 

and the competitively bid item(s) they 

wished to furnish to Medicare 

beneficiaries. CMS evaluated these bids 

and contracted with those suppliers that 

met all program requirements. The first 

round of bidding was successfully 

implemented on July 1, 2008. 

On July 15, 2008, however, Congress 

delayed this program in section 154 of 

the Medicare Improvements for Patients 

and Providers Act of 2008 (MIPPA). 

MIPPA mandated certain changes to the 

competitive bidding program which 

included, but are not limited to: A delay 

of Rounds 1 (competition began in 2009) 

and 2 of the program (competition began 

in 2011 in 70 specific MSAs); the 

exclusion of Puerto Rico and negative 

pressure wound therapy from Round 1 

and group 3 complex rehabilitative 

power wheelchairs from all rounds of 

competition; a process for providing 

feedback to suppliers regarding missing 

financial documentation; and a 

requirement for contract suppliers to 

disclose to CMS information regarding 

subcontracting relationships. Section 

154 of the MIPPA specified that the 

competition for national mail order 

items and services may be phased in 

after 2010 and established a rule 

requiring that a bidder demonstrate that 

its bid covers 50 percent (or higher) of 

the types of diabetic testing strips, based 

on volume (the ‘‘50 percent rule’’) for 

national mail order competitions. As 

required by MIPPA, CMS conducted the 

competition for the Round 1 Rebid in 

2009. The Round 1 Rebid contracts and 

prices became effective on January 1, 

2011. 

The Affordable Care Act, enacted on 

March 23, 2010, expanded the Round 2 

competition by adding an additional 21 

MSAs, bringing the total MSAs for 

Round 2 to 91. The competition for 

Round 2 began in December 2011. CMS 

also began a competition for National 

Mail Order of Diabetic Testing Supplies 

at the same time as Round 2. The Round 

2 and National Mail-Order contracts and 

prices have a target implementation date 

of July 1, 2013. 

The MMA requires the Secretary to recompete contracts not less often than 

once every 3 years. Most Round 1 Rebid 

contracts will expire on December 31, 

2013. (Round 1 Rebid contracts for mailorder diabetic testing supplies ended on 

December 31, 2012.) Consequently, we 

are currently in the process of recompeting the competitive bidding 

contracts in the Round 1 Rebid areas. 

The most recent approval for this 

information collection request (ICR) was 

issued by OMB on October 10, 2012. 

Since then, CMS has decided to 

sequentially update the paperwork 

burden necessary to administer the 

program as it expands nationally and 

cycles through multiple rounds of 

competition. Specifically, we are now 

seeking to update our burden estimates 

for certain contract maintenance forms 

for Round 2 and the national mail-order 

competitions. These include Form C 

and the Contract Supplier’s Disclosure 

of Subcontractors form. We are also 

requesting approval of two additional 

forms: The Change of Ownership 

(CHOW) Purchaser Form and the CHOW 

Contract Supplier Notification Form, 

which will be utilized in all rounds of 

competition. Finally, we are retaining 

without change Forms A, B, and D and 

their associated burden under this ICR. 

We note that the information collection 

for Forms A and B is already complete. 

We intend to continue use of the Forms 

in future rounds of competition. Form 

Number: CMS–10169 (OCN: 0938– 

1016). Frequency: Occasionally. 

Affected Public: Private Sector (business 

or other for-profits) and Individuals or 

households. Number of Respondents: 

19,035. Total Annual Responses: 

19,035. Total Annual Hours: 9,311. (For 

policy questions regarding this 

collection contact Michael Keane at 

410–786–4495. For all other issues call 

410–786–1326.) 

To obtain copies of the supporting 

statement and any related forms for the 

proposed paperwork collections 

referenced above, access CMS’ Web site 

address at http://www.cms.hhs.gov/ 

PaperworkReductionActof1995, or 

Email your request, including your 

address, phone number, OMB number, 

and CMS document identifier, to 

Paperwork@cms.hhs.gov, or call the 

Reports Clearance Office on (410) 786– 

1326. 

In commenting on the proposed 

information collections please reference 

the document identifier or OMB control 

number. To be assured consideration, 

comments and recommendations must 

be submitted in one of the following 

ways by April 30, 2013: 

1. Electronically. You may submit 

your comments electronically to http:// 

www.regulations.gov. Follow the 

instructions for ‘‘Comment or 

Submission’’ or ‘‘More Search Options’’ 

to find the information collection 

document(s) accepting comments. 

2. By regular mail. You may mail 

written comments to the following 

address: CMS, Office of Strategic 

Operations and Regulatory Affairs, 

Division of Regulations Development, 

Attention: Document Identifier/OMB 

Control Number lll, Room C4–26– 

05, 7500 Security Boulevard, Baltimore, 

Maryland 21244–1850. 

mstockstill on DSK4VPTVN1PROD with NOTICES

13880 Federal Register / Vol. 78, No. 41 / Friday, March 1, 2013 / Notices 

Dated: February 26, 2013. 

Martique Jones, 

Deputy Director, Regulations Development 

Group, Office of Strategic Operations and 

Regulatory Affairs. 

[FR Doc. 2013–04752 Filed 2–28–13; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Clinical Center; Notice of Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the NIH 

Advisory Board for Clinical Research. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in section 

552b(c)(6), Title 5 U.S.C., as amended to 

discuss personnel matters, the 

disclosure of which would constitute a 

clearly unwarranted invasion of privacy. 

Name of Committee: NIH Advisory Board 

for Clinical Research. 

Date: March 18, 2013. 

Open: 10:00 a.m. to 1:15 p.m. 

Agenda: To review the FY14 Clinical 

Center Budget. 

Place: National Institutes of Health, 

Building 10, 10 Center Drive, CRC Medical 

Board Room 4–2551, Bethesda, MD 20892. 

Closed: 1:15 p.m. to 2:00 p.m. 

Agenda: To discuss personnel matters and/ 

or issues of which the premature disclosure 

may affect outcomes. 

Place: National Institutes of Health, 

Building 10, 10 Center Drive, CRC Medical 

Board Room 4–2551, Bethesda, MD 20892. 

Contact Person: Maureen E Gormley, 

Executive Secretary, Mark O. Hatfield 

Clinical Research Center, National Institutes 

of Health, Building 10, Room 6–2551, 

Bethesda, MD 20892, (301) 496–2897. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Dated: February 25, 2013. 

Michelle Trout, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2013–04740 Filed 2–28–13; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Heart, Lung, and 

Blood Initial Review Group, Heart, Lung, and 

Blood Program Project Review Committee. 

Date: March 22, 2013. 

Time: 8:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Doubletree Hotel Bethesda, 

(Formerly Holiday Inn Select), 8120 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: Jeffrey H Hurst, Ph.D., 

Scientific Review Officer, Office of Scientific 

Review/DERA, National Heart, Lung, and 

Blood Institute, National Institutes of Health, 

6701 Rockledge Drive, Room 7208, Bethesda, 

MD 20892, 301–435–0303, 

hurstj@nhlbi.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS) 

Dated: February 25, 2013. 

Michelle Trout, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2013–04739 Filed 2–28–13; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Systems 

Biology and Networks Specials. 

Date: March 12, 2013. 

Time: 3:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Barbara J Thomas, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2218, 

MSC 7890, Bethesda, MD 20892, 301–435– 

0603, bthomas@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: February 25, 2013. 

Melanie J. Gray, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2013–04736 Filed 2–28–13; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

mstockstill on DSK4VPTVN1PROD with NOTICES